Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

INDIV 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Urinary Tract Infections 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1Sepsis 1Seizures 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1Retinitis 1Renal Insufficiency, Chronic 1Pulmonary Arterial Hypertension 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia 1Pancreatic Neoplasms 1Pain 1Neutropenia 1Myasthenia Gravis 1Migraine Disorders 1Menorrhagia 1Meningitis, Bacterial 1Meningitis 1Intraabdominal Infections 1Influenza, Human 1Inflammation 1Infections 1Hypokalemia 1Hypertension 1Hyperaldosteronism 1Herpes Simplex 1Hemophilia A 1

Interventions

ravulizumab 3Tacrolimus 3Pyridostigmine Bromide 3Prednisone 3Mycophenolic Acid 3Data Collection 3Azathioprine 3efgartigimod alfa 2Steroids 2Diagnostic Self Evaluation 2Blood Specimen Collection 2rozanolixizumab 1Thymectomy 1Therapeutics 1Telemedicine 1Neurofeedback 1Methylprednisolone 1Methotrexate 1Immunosuppressive Agents 1Immunoglobulins, Intravenous 1Genotype 1Cyclosporine 1Cyclophosphamide 1Biomarkers 1Alleles 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Myasthenia Gravis × Methylprednisolone × Clear all
NCT04101578 2021-08-23

Clinical Prognosis and Progression of Myasthenia Gravis Patients

Da, Yuwei, M.D.

Unknown
2,000 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡